Cytokinetics Inc (CYTK) — Working Capital to Net Assets Ratio
Cytokinetics Inc (CYTK) has a Working Capital to Net Assets ratio of -592.0% as of June 2026. Working capital of $1.03 Billion (current assets of $1.21 Billion minus current liabilities of $181.43 Million) is measured against net assets of $-173.49 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See operational self-sufficiency of Cytokinetics Inc to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Cytokinetics Inc Working Capital to Net Assets (2002–2025)
This chart shows how Cytokinetics Inc's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2002 to 2025. As of June 2026, the ratio stands at -592.0%, reflecting working capital of $1.03 Billion against net assets of $-173.49 Million USD. For the complete balance sheet picture, see CYTK total asset value.
Annual Working Capital to Net Assets for Cytokinetics Inc (2002–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Cytokinetics Inc from 2002 to 2025, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check financial resilience of Cytokinetics Inc to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -108.3% | $714.52 Million | $-659.62 Million | $916.98 Million | $202.45 Million | ▲ +577.4 pp |
| 2024 | -685.7% | $928.27 Million | $-135.37 Million | $1.11 Billion | $179.67 Million | ▼ -549.7 pp |
| 2023 | -136.0% | $525.37 Million | $-386.32 Million | $628.05 Million | $102.68 Million | ▲ +522.6 pp |
| 2022 | -658.5% | $710.57 Million | $-107.90 Million | $795.19 Million | $84.62 Million | ▼ -848.7 pp |
| 2021 | 190.2% | $463.81 Million | $243.86 Million | $535.67 Million | $71.86 Million | ▼ -200.5 pp |
| 2020 | 390.7% | $443.02 Million | $113.38 Million | $474.22 Million | $31.20 Million | ▲ +2290.1 pp |
| 2019 | -1899.3% | $207.73 Million | $-10.94 Million | $233.75 Million | $26.02 Million | ▼ -2614.5 pp |
| 2018 | 715.2% | $185.48 Million | $25.93 Million | $207.67 Million | $22.19 Million | ▲ +495.0 pp |
| 2017 | 220.2% | $241.85 Million | $109.84 Million | $274.30 Million | $32.44 Million | ▲ +87.3 pp |
| 2016 | 132.9% | $125.38 Million | $94.36 Million | $158.63 Million | $33.26 Million | ▲ +14.1 pp |
| 2015 | 118.8% | $81.46 Million | $68.59 Million | $113.11 Million | $31.65 Million | ▲ +2.2 pp |
| 2014 | 116.5% | $107.28 Million | $92.06 Million | $131.13 Million | $23.86 Million | ▲ +19.8 pp |
| 2013 | 96.7% | $52.63 Million | $54.44 Million | $79.34 Million | $26.70 Million | ▼ -2.3 pp |
| 2012 | 98.9% | $70.68 Million | $71.44 Million | $76.43 Million | $5.75 Million | ▲ +2.3 pp |
| 2011 | 96.6% | $46.55 Million | $48.18 Million | $51.14 Million | $4.59 Million | ▲ +2.8 pp |
| 2010 | 93.8% | $66.17 Million | $70.52 Million | $73.50 Million | $7.32 Million | ▼ -1.5 pp |
| 2009 | 95.4% | $96.74 Million | $101.43 Million | $116.92 Million | $20.18 Million | ▲ +23.0 pp |
| 2008 | 72.4% | $36.03 Million | $49.77 Million | $58.91 Million | $22.88 Million | ▼ -23.2 pp |
| 2007 | 95.6% | $95.57 Million | $99.92 Million | $122.02 Million | $26.45 Million | ▼ -24.0 pp |
| 2006 | 119.7% | $127.23 Million | $106.31 Million | $153.62 Million | $26.39 Million | ▲ +27.8 pp |
| 2005 | 91.9% | $67.60 Million | $73.56 Million | $78.86 Million | $11.26 Million | ▲ +0.8 pp |
| 2004 | 91.1% | $98.03 Million | $107.56 Million | $109.07 Million | $11.04 Million | ▲ +121.2 pp |
| 2003 | -30.0% | $27.62 Million | $-92.03 Million | $37.08 Million | $9.46 Million | ▲ +0.6 pp |
| 2002 | -30.7% | $18.57 Million | $-60.59 Million | $27.95 Million | $9.38 Million | — |